Methylethyltryptamine: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{Psychoactive substance}} | {{Psychoactive substance}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 03:43, 11 February 2025
Methylethyltryptamine (also known as MET) is a psychedelic and hallucinogenic drug. It is structurally related to dimethyltryptamine (DMT) and ethylisopropyltryptamine (EIPT), and is considered to be a member of the tryptamine class of compounds.
Chemistry
Methylethyltryptamine is a synthetic compound of the tryptamine class. Tryptamines share a core structure comprised of a bicyclic indole heterocycle attached at R3 to an amino group via an ethyl side chain. MET is substituted at R1 of its indole heterocycle with a methyl group, it also contains two ethyl chains bound to the terminal amine RN of its tryptamine backbone (MET).
Pharmacology
The pharmacology of methylethyltryptamine is not well-studied. However, like other tryptamines, it is thought to act primarily as a serotonin receptor agonist. It may also have effects on other neurotransmitter systems.
Effects
The effects of methylethyltryptamine can vary widely, depending on the dose and individual's physiology. Common effects include visual hallucinations, altered thinking processes, and a sense of euphoria. Some users also report experiencing a sense of spiritual insight or enlightenment.
Risks
As with any psychedelic drug, the use of methylethyltryptamine carries risks. These can include psychological distress, dangerous behavior, and negative physical reactions. It is also possible for the drug to interact negatively with other substances or medications.
Legal Status
The legal status of methylethyltryptamine varies by country. In some places, it is a controlled substance, while in others it is legal to possess and use.
See Also
| Psychoactive substances | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This psychoactive substance-related article is a stub.
|
